EPHB4 and breast carcinoma: Small-interfering-RNA (siRNA)-mediated knockdown of EphB4 expression resulted in a dose-dependent decrease in cell survival, increased apoptosis, and a heightened sensitivity to the tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) in breast cancer [45].